Clinically proven: Minimal irritation and high patient satisfaction
In a 3-week facial irritation evaluation of users of Obagi Retinol 1.0 Cream, investigators observed:1,*
- No statistically significant difference in erythema or dryness vs baseline at any point in the study
- No flaking observed in any participant during the course of the study
Patients were also highly satisfied with Retinol 1.0%:1,*
- 90% saw an improvement in facial appearance
- 88% felt their skin was more resilient
- 88% would purchase the product
- 88% would recommend the product to a friend